Berman Capital Advisors’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$1K Sell
46
-55
-54% -$1.44K ﹤0.01% 1888
2021
Q2
$2K Buy
101
+36
+55% +$1.07K ﹤0.01% 1605
2021
Q1
$2K Hold
65
﹤0.01% 1520
2020
Q4
$2K Hold
65
﹤0.01% 1409
2020
Q3
$2K Hold
65
﹤0.01% 1303
2020
Q2
$1K Buy
65
+1
+2% +$24 ﹤0.01% 1440
2020
Q1
$1K Hold
64
﹤0.01% 1312
2019
Q4
$1K Hold
64
﹤0.01% 1338
2019
Q3
$1K Buy
+64
New +$1.24K ﹤0.01% 1324

Other funds holding INSM

Berman Capital Advisors's INSM Position: Q3 2021 in Review

Berman Capital Advisors reduced its Insmed (INSM) stake by 54% in Q3 2021, selling an estimated $1.44K and leaving 46 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #1888.

Berman Capital Advisors first reported a position in INSM in Q3 2019 and has held it in 9 quarters since. The position peaked at $2K in Q2 2021. 193 funds tracked by Wall St. Rank hold INSM as of Q3 2021.

  • Berman Capital Advisors held 46 shares of Insmed worth $1K as of Q3 2021.
  • Berman Capital Advisors sold 55 Insmed shares in Q3 2021, an estimated $1.44K.
  • Insmed made up ﹤0.01% of Berman Capital Advisors's portfolio in Q3 2021, its #1888 holding.
  • Berman Capital Advisors first reported a position in Insmed in Q3 2019 and has held it in 9 quarters since.
  • Berman Capital Advisors's Insmed position peaked at $2K in Q2 2021.
  • 193 funds tracked by Wall St. Rank held Insmed as of Q3 2021.

Based on Berman Capital Advisors's 13F filing for Q3 2021, filed 7 Oct 2021.